If pregnancy had a “group chat,” the TORCH screen would be that one friend who pops in with: “Hey, just checkingare we sure nobody invited a sneaky infection to this party?” It’s not a vibe-killer; it’s a safety check. And like any safety check, it’s most useful when you know what it can and can’t tell you.

In this guide, we’ll break down what a TORCH screen is, why it’s ordered, how it’s done, and how to interpret common results (especially those confusing IgG/IgM antibodies). We’ll also talk about why many clinicians now prefer targeted testing over a one-size-fits-all “TORCH panel,” and what usually happens after the results come back.

What Is a TORCH Screen?

“TORCH” is an acronym for a group of infections that can be passed from a pregnant person to a fetus (during pregnancy) or to a newborn around the time of delivery. These infections are grouped together because they can cause similar problems in babieslike growth issues, rash, jaundice, eye findings, hearing loss, or neurologic complicationsespecially if infection happens early in pregnancy.

The tricky part: people use “TORCH screen” to mean two slightly different things:

• Newborn TORCH screen: blood testing (and sometimes other samples) ordered when a baby shows signs that suggest a congenital infection.
• Prenatal TORCH panel: antibody testing ordered during pregnancy when there’s a specific concern (symptoms, exposures, ultrasound findings), though routine “screen everyone” TORCH panels are generally discouraged in many settings.

What does TORCH stand for?

The classic TORCH infections are:

• T = Toxoplasmosis
• O = “Other” infections (often includes syphilis; sometimes hepatitis B, varicella, parvovirus B19, and more)
• R = Rubella
• C = Cytomegalovirus (CMV)
• H = Herpes simplex virus (HSV)

Some references include HIV under the TORCH umbrella, and you may also see “TORCHS” where the extra S stands for syphilis. The exact list depends on the lab and the clinical situation.

Why TORCH Infections Matter in Pregnancy and Newborns

During pregnancy, the placenta does an incredible job acting like a bouncerletting nutrients in, keeping most trouble out. But some infections can slip through, especially if the pregnant person has a new (primary) infection. Newborns can also be exposed during delivery or shortly after birth.

TORCH infections are most concerning because they can affect developing organs. Timing matters:

• Early pregnancy: higher risk of serious developmental effects (depending on the infection).
• Later pregnancy: some infections transmit more easily later, but outcomes vary by pathogen.
• Around delivery: HSV exposure during birth is a classic example.

Signs that may raise suspicion

Clinicians typically consider congenital infection when they see certain patterns, such as:

• Intrauterine growth restriction (IUGR) or low birth weight
• Microcephaly or abnormal brain imaging
• Hepatosplenomegaly (enlarged liver/spleen), jaundice, elevated liver enzymes
• “Blueberry muffin” rash (purplish spots), petechiae
• Chorioretinitis or other eye findings
• Hearing loss (often discussed with CMV)
• Seizures, lethargy, or other neurologic symptoms

When Is a TORCH Screen Ordered?

In pregnancy (prenatal testing)

A prenatal TORCH panel may be ordered when there’s a specific reason to suspect infectionsuch as:

• Ultrasound findings that suggest possible congenital infection (for example: intracranial calcifications, ventriculomegaly, growth restriction)
• A known exposure (e.g., contact with someone diagnosed with rubella, or high-risk toxoplasma exposure)
• Symptoms consistent with acute infection in the pregnant person
• Clarifying immunity status (most commonly rubella IgG immunity checks)

Important nuance: many professional sources emphasize that routine blanket screeningespecially for CMV or HSVcan create confusion because antibody tests (particularly IgM) can be hard to interpret and may be falsely positive. That’s why many clinicians prefer ordering targeted, infection-specific tests based on the clinical picture.

In newborns (postnatal testing)

In a newborn, a TORCH screen is usually considered when a baby has symptoms or findings that suggest congenital infection. A key point: a “TORCH screen” is not the same thing as the routine state newborn screening (the heel-prick metabolic screen). It’s a separate diagnostic evaluation.

Procedure: How the TORCH Screen Is Done

Step 1: Sample collection

Most TORCH screening starts with a blood sample:

• Pregnant person: blood draw from a vein (standard lab draw).
• Newborn: small blood sample (method varies by hospital and test).

Depending on what the clinician suspects, additional samples may be usedbecause some infections are best confirmed with something more specific than antibodies alone:

• Urine or saliva PCR testing (commonly discussed for congenital CMV)
• Swabs and PCR/culture (especially for HSV when lesions or exposure are a concern)
• Amniotic fluid testing in pregnancy (in select situations, guided by specialists)

Step 2: What the lab actually measures

Many TORCH panels are antibody-based tests that look for:

• IgG antibodies: often indicate past infection or immunity (including vaccination immunity for rubella).
• IgM antibodies: can suggest recent infectionbut can also be falsely positive or persist longer than people expect.

Step 3: Turnaround time

Many commercial lab panels return within a few days, but confirmatory testing and reflex tests (like avidity testing, inhibition assays, or PCR confirmation) may take longer. In urgent newborn evaluations, clinicians often order the most time-sensitive confirmatory tests right away.

Results: How to Understand TORCH Antibody Testing (IgG vs IgM)

If antibody results feel like they were designed by a committee that hates happiness, you’re not alone. Here’s the practical way to think about them:

IgG: “Have we met before?”

A positive IgG often means the immune system has seen the organism before. In pregnancy, that can be reassuring for some infections (for example, rubella IgG positivity generally suggests immunity). But IgG alone typically does not prove a new infection is happening right now.

IgM: “This might be new… or it might be complicated.”

IgM can rise early in infection, but it’s notorious for:

• False positives (test cross-reactivity, nonspecific immune activity)
• Persistent positivity after infection has passed
• Misleading results after vaccination (notably with rubella IgM in certain contexts)

That’s why many clinicians do not act on IgM alone. Instead, they often use a combination of:

• Repeat testing (paired samples 10–14 days apart to look for rising IgG)
• IgG avidity testing (helps estimate how recently infection happened for some pathogens)
• PCR testing for viral DNA/RNA in appropriate specimens
• Clinical context (symptoms, ultrasound findings, timing, exposures)

Pathogen-by-Pathogen: What Results Often Mean

Different infections play by different rules. Here’s a clinician-style “cheat sheet” that keeps the spirit of the science without turning your brain into soup.

Toxoplasmosis

Toxoplasma testing commonly includes IgG and IgM. A classic pitfall is that IgM can be falsely positive. If IgG and IgM are both positive in pregnancy, clinicians often use IgG avidity (especially early in pregnancy) to help determine whether infection is likely recent or more remote.

Example: A pregnant patient has positive toxoplasma IgM on a panel ordered “just to be safe.” If avidity is high (suggesting older exposure), that can be reassuring and prevent unnecessary panic. If avidity is low and the timing fits, the clinician may pursue more targeted evaluation.

Rubella

Rubella IgG is often used to assess immunity before, during, or after pregnancy. In the U.S., clinicians commonly check rubella immunity as part of preconception or prenatal labs. Routine rubella IgM screening isn’t generally recommended unless there’s a reason to suspect infection.

Example: A rubella IgG result comes back positive in early prenatal labs. That typically means immunity (from vaccination or prior infection), and it’s one of the few times a positive antibody result can genuinely feel like a gold star.

Cytomegalovirus (CMV)

CMV is common, and most adults have been exposed at some point. The hard part is determining whether a pregnant person has a primary infection that might pose fetal risk. CMV IgM alone can be misleading, so clinicians may combine IgM with IgG avidity or use other methods based on timing and clinical findings.

For newborns, diagnosis of congenital CMV is time-sensitive. Testing (often saliva screening with confirmatory urine PCR) is typically discussed within a narrow window after birth to distinguish congenital infection from postnatal acquisition.

Herpes simplex virus (HSV)

HSV in pregnancy is a special case because the biggest risk to the newborn is often related to exposure during delivery, especially when a pregnant person has a new infection late in pregnancy or active lesions at delivery.

Serology (blood antibody testing) can show prior exposure, but it doesn’t necessarily tell you what’s happening right now, and routine screening in asymptomatic people isn’t generally recommended. When HSV is suspected in a newborn, clinicians typically use PCR testing from swabs and other clinical evaluation rather than relying on antibodies alone.

“Other” infections

The “O” in TORCH varies. Syphilis is a common “other” included in many discussions (hence TORCHS). Depending on symptoms and pregnancy history, clinicians may also consider hepatitis B, HIV, varicella-zoster virus, parvovirus B19, and othersusually through targeted tests rather than a catch-all panel.

Why Many Clinicians Prefer Targeted Testing Over a Big TORCH Panel

TORCH panels sound efficientone order, lots of answers. In reality, broad panels can produce:

• Low-yield results when there’s no strong clinical suspicion
• False positives (especially IgM), leading to stress and unnecessary follow-up
• Ambiguous “maybe” answers that don’t change management

Many modern approaches start with a clinical question (“Are we worried about CMV based on ultrasound and timing?”) and then choose the best tests for that question (serology + avidity, PCR, confirmatory testing, specialist input).

What Happens After Results Come Back?

Next steps depend on whether testing was done in pregnancy or after birth, and which infection is suspected. Common follow-ups include:

• Repeat bloodwork to look for changing antibody levels
• Confirmatory tests (avidity assays, inhibition assays, reference-lab confirmation)
• PCR testing on appropriate specimens for definitive evidence of infection
• Targeted imaging (often ultrasound in pregnancy; sometimes neonatal imaging depending on symptoms)
• Specialist referral (maternal-fetal medicine, pediatric infectious disease, audiology, ophthalmology)

The most important “result interpretation rule” is this: a single test rarely tells the whole story. Clinicians interpret TORCH testing in the context of timing, symptoms, exposures, and confirmatory findings.

Practical Prevention Tips (Because “Don’t Get Infected” Is Not a Plan)

CMV

CMV often spreads through contact with saliva or urineespecially from young children. Practical steps may include careful handwashing after diaper changes and avoiding sharing utensils or toothbrushes with toddlers (easy to say, harder when your toddler is basically a sticky hug machine).

Toxoplasmosis

Risk reduction often focuses on food safety (thoroughly cooking meat, washing produce) and avoiding exposure to cat feces (someone else cleans the litter box, or you use gloves and wash hands carefully).

Rubella

Rubella prevention centers on vaccination before pregnancy. In the U.S., rubella immunity is commonly checked and non-immune individuals are typically advised to get vaccinated after pregnancy rather than during it.

HSV

For HSV, prevention is about reducing exposure (safer sex practices, awareness of symptoms, and clinician-guided management in pregnancy if there’s known HSV). If there are active lesions near delivery, the delivery plan may change to reduce neonatal risk.

Frequently Asked Questions

Is a TORCH screen a routine prenatal test?

Usually, no. Some components (like rubella IgG for immunity status) may be routine, but a full TORCH panel is typically reserved for specific concerns. Routine screening for certain infections (notably CMV and HSV serology in asymptomatic pregnant people) is often discouraged because of interpretation issues.

Can TORCH results tell exactly when the infection happened?

Not exactly. Antibody patterns can suggest timing, and avidity testing can sometimes help estimate whether infection is likely recent versus remote, but it’s not a perfect timestamp. Clinicians frequently use repeat testing and/or PCR when timing matters.

Does a positive result mean my baby will definitely be harmed?

No. Risk varies widely by infection, timing, and whether it’s a primary infection. Many babies exposed to certain infections do well, and many abnormal TORCH results turn out to be false alarms or evidence of old exposure. That’s why confirmation and context are essential.

Conclusion

The TORCH screen can be a helpful tool when there’s a clear reason to suspect a congenital infectionbut it’s not a crystal ball, and it’s not always the best first test. Understanding the basics (especially the difference between IgG and IgM) can help you ask smarter questions, avoid unnecessary panic, and focus on the follow-up that actually clarifies what’s going on.

If you’re offered TORCH testing (or you’ve already received results), the most useful next step is usually the same: talk with your clinician about what question the test is trying to answer and whether confirmatory, targeted testing is needed.

Real-World Experiences: What TORCH Testing Feels Like (and What People Learn)

TORCH testing doesn’t just happen in a labit happens in real lives, usually at moments when people are already stressed. One common experience is that TORCH panels are sometimes ordered after an ultrasound shows a vague finding (like “baby is measuring small” or “there’s a spot we want to re-check”). If you’ve been on the receiving end of that phone call, you know the emotional whiplash: you went in expecting cute ultrasound photos and left with the medical version of a “we need to talk.”

Many patients describe the waiting as the hardest part. Blood draws are quick; interpretation is not. Antibody results can come back with words like “equivocal,” “indeterminate,” or “positive IgM,” and those labels can feel dramaticespecially if you Google them at 2 a.m. (No judgment. The internet was basically built for 2 a.m. spirals.) What often surprises people is that clinicians may respond to a “positive” result with calm skepticism. That’s not dismissal; it’s experience. Many providers have seen IgM tests misbehave, and they know that confirmatory stepsrepeat testing, avidity, PCRare what separate a true current infection from a lab mirage.

Another real-world pattern: TORCH testing can shift from “pregnancy question” to “newborn question” quickly. For example, a baby might be born with jaundice, petechiae, or hearing-screen issues, and suddenly the focus is on time-sensitive confirmatory tests and specialist input. Parents often report that having a clear explanation of why each test is being ordered“We’re checking for CMV using a sample that’s best within the first few weeks” or “We’re using PCR because antibodies won’t tell us what we need”helps them feel less like passengers and more like informed participants.

Clinicians have their own “TORCH testing memories,” too. Many describe TORCH panels as a double-edged sword: convenient, but sometimes too broad. A seasoned approach often comes from seeing how frequently broad panels create noise. Providers learn to ask: “What infection would actually explain these findings?” and “What test will answer that question most reliably?” That’s why many teams now favor targeted algorithms over ordering everything all at once.

Finally, a hopeful note: people often walk away from TORCH testing with a clearer plan, even if the plan is simply “this looks like past immunity” or “we’ll repeat in two weeks.” In many cases, the experience becomes less about the panel itself and more about building a roadmapwhat’s likely, what’s unlikely, and what steps will definitively clarify things. In other words: fewer scary guesses, more grounded answers. And in pregnancy, “grounded answers” is basically the deluxe upgrade package.